ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
ANI Pharmaceuticals (Nasdaq: ANIP) announced that CEO Nikhil Lalwani will present at the 44th Annual J.P.
Rhea-AI Summary
ANI Pharmaceuticals (Nasdaq: ANIP) announced that CEO Nikhil Lalwani will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 at 3:00 p.m. PT / 6:00 p.m. ET.
The presentation will be available via a live webcast and an archived replay on the company website under Investors > Events and Presentations. The replay will be accessible for 30 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ANIP
On Jan 7, the first trading day after this news, ANIP closed 2.57% above the previous close.
Data tracked by StockTitan Argus for the Jan 7 session.
Key Figures
- Conference date
- January 13, 2026
- J.P. Morgan Healthcare Conference presentation timing
- Presentation time PT
- 3:00 p.m. PT
- Scheduled start time for CEO presentation
- Presentation time ET
- 6:00 p.m. ET
- Scheduled start time for CEO presentation
- Webcast replay period
- 30 days
- Duration replay will be accessible on company website
Historical Context
-
Formed FutureVision Advisory Council for ophthalmology and retina franchise guidance.
-
Orderly board chair transition framed around continuity and Rare Disease expansion.
-
CEO fireside chat at Piper Sandler healthcare conference with webcast access.
-
CEO fireside chat at Jefferies Global Healthcare Conference in London.
-
Record Q3 2025 results and raised 2025 revenue, EBITDA, and EPS guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:00 p.m. PT / 6:00 p.m. ET.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 30 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Courtney Mogerley, Argot Partners
E: ani@argotpartners.com
Media Relations:
Deborah Elson, Argot Partners
E: ani@argotpartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.